Research News

Research News | Oct. 28, 2013

In Treatment Adherence Study, Many Medicaid Beneficiaries Struggled to Stay on Medications

Researchers from the University of California and Brigham and Women’s Hospital in Boston recently examined adherence among Medicaid beneficiaries with lupus to prescribed medications and found the patients were not following treatment plans, putting themselves at risk for poor outcomes.

Research News | Oct. 17, 2013

New Review Summarizes the Risk of Heart Disease and Stroke Among People with Lupus

A new study summarizes the best available evidence regarding the risk of heart disease and stroke among people with lupus.

Research News | Sep. 12, 2013

New Light Shed on Photosensitivity among People with Lupus

Photosensitivity or abnormal light sensitivity is very complex and is a major symptom of lupus. Now, a new, small study sheds more light on photosensitivity among people with lupus. Learn more.

Research News | Aug. 16, 2013

Adult Stems Cells in the Treatment of Lupus - Where are we now?

Cell based therapies are a growing interest in all areas of medicine as they are viewed as long term solutions rather than temporary fixes. A recent journal article highlights progress made in better understanding the potential for two basic types of adult stem cells.

Research News | Aug. 15, 2013

Pilot Study Sheds Light on a Potential New Approach for Treating Lupus Nephritis

Lupus nephritis, which can damage and scar the kidneys, is one of the most common and serious complications of lupus. This new study suggests that with the right induction regimen, it may be possible to avoid maintenance (long-term) treatment with oral steroids.

Research News | Aug. 01, 2013

New Progress in Assessing Neuropsychiatric Lupus in Children

A new study conducted at Cincinnati Children’s Hospital Medical Center (CCHMC) suggests that neuroimaging methods such as functional magnetic resonance imaging (fMRI) may help identify biomarkers for children with NPSLE, particularly those with cognitive impairments.

Research News | Jun. 03, 2013

Early Use of Hydroxychloroquine May Protect Against Organ Damage in Lupus

People with lupus who were treated with hydroxychloroquine (HCQ), an anti-malarial drug, early after a diagnosis of lupus had less cumulative organ damage at three years after diagnosis than those who did not receive HCQ, according to a new analysis.

Research News | Mar. 26, 2013

Increased Incidence of Shingles in People with Lupus

A study published in a recent issue of the journal Lupus reports that people with lupus had a 70 percent increased risk of developing shingles compared to participants without inflammatory disease.